Bioenergetic gain of citrate-anticoagulated continuous renal replacement therapy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10322857" target="_blank" >RIV/00216208:11110/15:10322857 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/15:10322857

Výsledek na webu

<a href="http://dx.doi.org/10.1007/978-1-4614-7836-2_70" target="_blank" >http://dx.doi.org/10.1007/978-1-4614-7836-2_70</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-1-4614-7836-2_70" target="_blank" >10.1007/978-1-4614-7836-2_70</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Bioenergetic gain of citrate-anticoagulated continuous renal replacement therapy

Popis výsledku v původním jazyce

The cumulative evidence indicating both efficacy and safety of regional citrate anticoagulation (RCA) has been reflected in recent KDIGO guidelines suggesting the use of citrate for prevention of filter clotting in preference to standard heparin, even inpatients without an increased bleeding risk. In this chapter we discuss homeostatic consequences of various citrate modalities and bioenergetic gains of various forms of citrate-based continuous renal replacement therapy (CRRT). A systemic dosage of citrate depends on the balance between citrate flow related directly to blood flow and citrate elimination in the effluent which is related to a set RRT dosage. The citrate dosage and systemic energetic delivery is also influenced by the presence or absenceof calcium in dialysis/substitution fluids which may be bicarbonate or lactate buffered. Associated homeostatic changes in acid-base regulation and ion changes develop parallely to energetic deliveries given by the loads of citrate, lact

Název v anglickém jazyce

Bioenergetic gain of citrate-anticoagulated continuous renal replacement therapy

Popis výsledku anglicky

The cumulative evidence indicating both efficacy and safety of regional citrate anticoagulation (RCA) has been reflected in recent KDIGO guidelines suggesting the use of citrate for prevention of filter clotting in preference to standard heparin, even inpatients without an increased bleeding risk. In this chapter we discuss homeostatic consequences of various citrate modalities and bioenergetic gains of various forms of citrate-based continuous renal replacement therapy (CRRT). A systemic dosage of citrate depends on the balance between citrate flow related directly to blood flow and citrate elimination in the effluent which is related to a set RRT dosage. The citrate dosage and systemic energetic delivery is also influenced by the presence or absenceof calcium in dialysis/substitution fluids which may be bicarbonate or lactate buffered. Associated homeostatic changes in acid-base regulation and ion changes develop parallely to energetic deliveries given by the loads of citrate, lact

Druh

C - Kapitola v odborné knize

CEP obor

FB - Endokrinologie, diabetologie, metabolismus, výživa

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Diet and Nutrition in Critical Care

ISBN

978-1-4614-7837-9

Počet stran výsledku

12

Strana od-do

359-370

Počet stran knihy

2137

Název nakladatele

Springer

Místo vydání

New York

Kód UT WoS kapitoly

—